SSA
INBX icon

Schonfeld Strategic Advisors’s Inhibrx INBX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.1M Buy
697,586
+442,759
+174% +$44.4M 0.24% 65
2026
Q1 		$17.1M Buy
254,827
+40,102
+19% +$2.97M 0.12% 188
2025
Q4 		$17M Buy
214,725
+117,343
+120% +$8M 0.08% 232
2025
Q3 		$3.28M Sell
97,382
-57,408
-37% -$1.41M 0.02% 793
2025
Q2 		$2.21M Buy
154,790
+10,612
+7% +$137K 0.02% 923
2025
Q1 		$2.02M Hold
144,178
– – 0.01% 964
2024
Q4 		$2.22M Hold
144,178
– – 0.01% 790
2024
Q3 		$2.26M Buy
144,178
+68,198
+90% +$958K 0.02% 829
2024
Q2 		$1.08M Buy
+75,980
New +$1.19M 0.01% 1176

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Schonfeld Strategic Advisors's INBX Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Inhibrx (INBX) stake by 174% in Q2 2026, buying an estimated $44.4M and bringing the position to 697,586 shares worth $66.1M. The position accounts for 0.24% of the portfolio, ranked #65.

Schonfeld Strategic Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Schonfeld Strategic Advisors held 697,586 shares of Inhibrx worth $66.1M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 442,759 Inhibrx shares in Q2 2026, an estimated $44.4M.
  • Inhibrx made up 0.24% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #65 holding.
  • Schonfeld Strategic Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.